APAF1 and cancer: In ovarian neoplasm, miRNA 21 derived from CAFs and cancer associated adipocytes was transferred to cancer cells, which conferred paclitaxel resistance by directly targeting apoptotic protease activating factor-1(APAF1) (Yeung et al., 2016).